Navigation Links
HPS Establishes Independent Website for its Patent-Pending Mood-Enhancing Compound Naturally Found in Sea Coral
Date:1/21/2009

SAN JOSE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") announced that it has established a website devoted to its newly-announced mood- enhancing compound, ER 303, for which the Company filed Comprehensive Patent Applications with both the U.S. Patent and Trademark Office and the International Bureau of the World Patent Office. On the site, the Company released additional data regarding the testing that was performed on male and female volunteers, which show significant improvement in several aspects of mood enhancement.

"We felt it appropriate to develop this website to respond to requests received about this innovative and previously undeveloped compound, with its origin in sea coral, which has significant emotional impacts on both men and women, enhancing feelings of positive social relationships, personal well- being and social attraction", a Company spokesperson noted. "Hopefully, the data contained on this site will answer initial questions that have been posed since the Company's original announcement", the spokesperson indicated.

In addition to the Company's earlier disclosure, the data included on http://www.ER303.com details the definitive results of the testing that was performed, and confirms that prior to the Company's reproduction of this naturally-occurring compound, it could only be found in coral reefs off the coasts of Newfoundland and in the waters off Brazil's Guiabinha Island.

The Company has previously been granted broad-based worldwide patents for its initial compound, Androstadienone, which has been licensed to leading marketers, including Johnson & Johnson, Avon and Schwarkopf and Henkel and its affiliates.

This news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company's results is detailed in the Company's annual report to shareholders on Form 10- KSB for the year ended December 31, 2007, and Form 10-Q for the nine months ended September 30, 2008 as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements.


'/>"/>
SOURCE Human Pheromone Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
2. Cystic Fibrosis Foundation Establishes Landmark Patient Assistance Foundation
3. Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting
4. Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
5. Halleland Health Consulting Establishes URAC Accreditation Program
6. Jenny Craig Establishes License Agreement for Volumetrics(R)
7. Disabled Veteran Establishes Non-Profit, AVHRT, to House Injured Veterans
8. Sonic Innovations Establishes Donation Fund for the Armed Forces Foundation
9. Leading Performance-Enhancing Drug Research Institute Anti-Doping Research (ADR) Establishes Nonprofit Status
10. AmeriCares Establishes Field Hospital in China
11. InterComponentWare Establishes ICW Labs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
Breaking Medicine Technology: